Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
+$784M |
| 2 |
Amgen
AMGN
|
+$695M |
| 3 |
Eli Lilly
LLY
|
+$512M |
| 4 |
Apple
AAPL
|
+$485M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$471M |
Top Sells
| 1 |
Adobe
ADBE
|
+$935M |
| 2 |
NVIDIA
NVDA
|
+$837M |
| 3 |
TJX Companies
TJX
|
+$533M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$364M |
| 5 |
Starbucks
SBUX
|
+$357M |
Sector Composition
| 1 | Technology | 35.94% |
| 2 | Healthcare | 18.89% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Integra LifeSciences
IART
$1.22B
| $982K | ﹤0.01% |
33,756
-349
| -1% | -$10.2K |
|
1627
United Parks & Resorts
PRKS
$2.77B
| $978K | ﹤0.01% |
18,006
-163
| -0.9% | -$8.85K |
|
1628
CAE Inc
CAE
$8.54B
| $976K | ﹤0.01% |
52,483
| – | – |
|
1629
Sunstone Hotel Investors
SHO
$1.8B
| $975K | ﹤0.01% |
93,188
-1,053
| -1% | -$11K |
|
|
FL
1630
DELISTED
Foot Locker
FL
| $973K | ﹤0.01% |
39,032
-422
| -1% | -$10.5K |
|
1631
Magna International
MGA
$13.2B
| $972K | ﹤0.01% |
23,249
| – | – |
|
1632
Teva Pharmaceuticals
TEVA
$22.7B
| $968K | ﹤0.01% |
59,563
| – | – |
|
|
HIBB
1633
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $967K | ﹤0.01% |
11,084
+1,192
| +12% | +$104K |
|
1634
10x Genomics
TXG
$1.63B
| $965K | ﹤0.01% |
49,688
+10,888
| +28% | +$211K |
|
1635
Myriad Genetics
MYGN
$687M
| $965K | ﹤0.01% |
39,469
-408
| -1% | -$9.97K |
|
1636
Materion
MTRN
$2.33B
| $965K | ﹤0.01% |
8,930
-105
| -1% | -$11.3K |
|
1637
Nuvalent
NUVL
$5.89B
| $963K | ﹤0.01% |
12,716
-134
| -1% | -$10.2K |
|
1638
Patria Investments
PAX
$2.32B
| $962K | ﹤0.01% |
79,679
-1,378,334
| -95% | -$16.6M |
|
1639
Equitable Holdings
EQH
$16.1B
| $961K | ﹤0.01% |
23,528
-6,664
| -22% | -$272K |
|
1640
Riot Platforms
RIOT
$6.16B
| $959K | ﹤0.01% |
105,123
+22,343
| +27% | +$204K |
|
1641
Quaker Houghton
KWR
$2.48B
| $956K | ﹤0.01% |
5,638
-71
| -1% | -$12K |
|
1642
Howard Hughes
HHH
$4.83B
| $956K | ﹤0.01% |
15,496
-2,892
| -16% | -$178K |
|
|
PDCO
1643
DELISTED
Patterson Companies, Inc.
PDCO
| $954K | ﹤0.01% |
39,547
-427
| -1% | -$10.3K |
|
1644
Clearway Energy Class C
CWEN
$3.4B
| $951K | ﹤0.01% |
38,562
-424
| -1% | -$10.5K |
|
1645
Celldex Therapeutics
CLDX
$1.69B
| $950K | ﹤0.01% |
25,642
-280
| -1% | -$10.4K |
|
1646
Werner Enterprises
WERN
$1.7B
| $948K | ﹤0.01% |
26,453
-324
| -1% | -$11.6K |
|
1647
Bread Financial
BFH
$2.99B
| $947K | ﹤0.01% |
21,242
-251
| -1% | -$11.2K |
|
1648
Fortrea Holdings
FTRE
$943M
| $946K | ﹤0.01% |
40,500
-458
| -1% | -$10.7K |
|
1649
Liberty Live Group Series C
LLYVK
$9.31B
| $946K | ﹤0.01% |
24,700
-234
| -0.9% | -$8.96K |
|
1650
Urban Edge Properties
UE
$2.68B
| $945K | ﹤0.01% |
51,125
-589
| -1% | -$10.9K |
|